Berlex Launches New Interactive Web Site for Menopausal And Postmenopausal Women

- Virtual Woman Offers Glance at the Effects of Menopause on a Woman's Body -



Apr 24, 2001, 01:00 ET from Berlex Laboratories, Inc.

    MONTVILLE, N.J., April 24 /PRNewswire Interactive News Release/ -- Berlex
 Laboratories, Inc., the U.S. affiliate of Schering AG, Germany (NYSE:   SHR),
 announced today the launch of a new web destination,
 http://www.climara-us.com, that offers women an interactive tool designed to
 demonstrate the effects of estrogen deficiency on various human organs by
 allowing them to click their way through the female body on a virtual tour.
     The platform, Virtual Woman, is an innovative feature of a comprehensive
 health information site that encompasses popular high-interest/important
 women's health topics such as hysterectomy, menopause and osteoporosis.  Users
 can access a wealth of information that is specific and relevant to their
 areas of concern.  Information includes symptoms, health risks and estrogen
 replacement therapy (ERT).
     "The tour of the Virtual Woman on climara-us.com combines factual
 information with a customized approach that will enable women to gain a better
 understanding of how their bodies change at menopause so they can take
 appropriate action to help maintain good health," said Reinhard Franzen, Vice
 President and General Manager, Female Healthcare, Berlex Laboratories, Inc.
     Also, the site features one of television's well-known personalities,
 actress/author Valerie Harper, who discusses her personal experience with
 menopause and the Climara(R) (estradiol transdermal system) estrogen
 replacement patch.  As a satisfied user, Ms. Harper explains that she uses the
 Climara patch because it delivers a low-dose of estrogen directly through the
 skin and into the bloodstream for seven full days.  She also provides insight
 into the inspiration for her new book, "Today I am a Ma'am: And Other Musings
 on Life, Beauty and Growing Older," which also provides humorous commentary
 about the changes women go through during menopause.
     "As a company dedicated to enhancing the quality of women's lives, Berlex
 is very proud to be working with Valerie Harper to encourage women to gain
 control of menopausal symptoms and to protect themselves against
 osteoporosis," added Franzen.
     The site is also a useful resource for all women seeking
 easy-to-understand information on the changes associated with natural or
 surgical menopause such as the hot flushes that they may experience.  It also
 offers women whom are considering estrogen replacement therapy visuals of the
 once-a-week Climara(R) (estradiol transdermal system) family of products as
 well as dosing options and important patient information.
     Women who use Climara - the most prescribed estrogen replacement therapy
 (ERT) patch in the U.S. - can benefit from visiting another new site,
 http://www.climararewards.com, where they can join Climara Rewards(TM).  This
 incentive program rewards its members for adopting a healthy lifestyle and
 using once-a-week Climara. The site also provides email refill reminders for
 each woman who enrolls in the program.  Members can earn valuable points each
 time they refill their Climara prescription.  The points are good toward
 healthy lifestyle merchandise available through an online catalog or members
 can elect to make a monetary contribution to several non-profit women's health
 organizations.  Some women may also be eligible for money-saving rebates on
 their Climara prescriptions.
     The U.S. Food and Drug Administration (FDA) recently approved Climara
 0.025 mg/day for the relief of menopausal symptoms and as the new recommended
 starting dose. Climara is now the only ERT available that provides the lowest
 effective dose of estrogen proven to treat menopausal symptoms and prevent
 osteoporosis.  Available in four dosage strengths, Climara is a thin, clear,
 flexible patch that is applied to the abdomen or buttock and changed once a
 week.  The patch delivers a steady supply of 17-beta estradiol -- the same
 estrogen a woman's ovaries produce before menopause -- directly through the
 skin and into the bloodstream for seven full days.  The estrogen in Climara is
 derived from natural plant sources (soy).
     Estrogens should not be used by patients with known or suspected
 pregnancy, breast cancer, estrogen-dependant neoplasia, undiagnosed abnormal
 genital bleeding, active thrombophlebitis, or thromboembolic disorders.
 Estrogens have been reported to increase the risk of endometrial carcinoma in
 women with a uterus.
     Committed to developing novel diagnostics and therapeutics that address
 unmet medical needs, Berlex Laboratories, Inc., the U.S. affiliate of Schering
 AG, Germany (NYSE:   SHR), researches, manufactures and markets ethical
 pharmaceuticals in five strategic areas: Diagnostic Imaging, Female
 Healthcare, Dermatology, Oncology and Therapeutics for life-threatening and
 disabling diseases.  Berlex has business operations located in Montville and
 Wayne, New Jersey, and in Richmond, California.  For more information on
 currently marketed products, please visit http://www.berlex.com.
     For further information about the Climara family of products, please visit
 http://www.climara-us.com or http://www.climararewards.com.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X29150011
 
 

SOURCE Berlex Laboratories, Inc.
    MONTVILLE, N.J., April 24 /PRNewswire Interactive News Release/ -- Berlex
 Laboratories, Inc., the U.S. affiliate of Schering AG, Germany (NYSE:   SHR),
 announced today the launch of a new web destination,
 http://www.climara-us.com, that offers women an interactive tool designed to
 demonstrate the effects of estrogen deficiency on various human organs by
 allowing them to click their way through the female body on a virtual tour.
     The platform, Virtual Woman, is an innovative feature of a comprehensive
 health information site that encompasses popular high-interest/important
 women's health topics such as hysterectomy, menopause and osteoporosis.  Users
 can access a wealth of information that is specific and relevant to their
 areas of concern.  Information includes symptoms, health risks and estrogen
 replacement therapy (ERT).
     "The tour of the Virtual Woman on climara-us.com combines factual
 information with a customized approach that will enable women to gain a better
 understanding of how their bodies change at menopause so they can take
 appropriate action to help maintain good health," said Reinhard Franzen, Vice
 President and General Manager, Female Healthcare, Berlex Laboratories, Inc.
     Also, the site features one of television's well-known personalities,
 actress/author Valerie Harper, who discusses her personal experience with
 menopause and the Climara(R) (estradiol transdermal system) estrogen
 replacement patch.  As a satisfied user, Ms. Harper explains that she uses the
 Climara patch because it delivers a low-dose of estrogen directly through the
 skin and into the bloodstream for seven full days.  She also provides insight
 into the inspiration for her new book, "Today I am a Ma'am: And Other Musings
 on Life, Beauty and Growing Older," which also provides humorous commentary
 about the changes women go through during menopause.
     "As a company dedicated to enhancing the quality of women's lives, Berlex
 is very proud to be working with Valerie Harper to encourage women to gain
 control of menopausal symptoms and to protect themselves against
 osteoporosis," added Franzen.
     The site is also a useful resource for all women seeking
 easy-to-understand information on the changes associated with natural or
 surgical menopause such as the hot flushes that they may experience.  It also
 offers women whom are considering estrogen replacement therapy visuals of the
 once-a-week Climara(R) (estradiol transdermal system) family of products as
 well as dosing options and important patient information.
     Women who use Climara - the most prescribed estrogen replacement therapy
 (ERT) patch in the U.S. - can benefit from visiting another new site,
 http://www.climararewards.com, where they can join Climara Rewards(TM).  This
 incentive program rewards its members for adopting a healthy lifestyle and
 using once-a-week Climara. The site also provides email refill reminders for
 each woman who enrolls in the program.  Members can earn valuable points each
 time they refill their Climara prescription.  The points are good toward
 healthy lifestyle merchandise available through an online catalog or members
 can elect to make a monetary contribution to several non-profit women's health
 organizations.  Some women may also be eligible for money-saving rebates on
 their Climara prescriptions.
     The U.S. Food and Drug Administration (FDA) recently approved Climara
 0.025 mg/day for the relief of menopausal symptoms and as the new recommended
 starting dose. Climara is now the only ERT available that provides the lowest
 effective dose of estrogen proven to treat menopausal symptoms and prevent
 osteoporosis.  Available in four dosage strengths, Climara is a thin, clear,
 flexible patch that is applied to the abdomen or buttock and changed once a
 week.  The patch delivers a steady supply of 17-beta estradiol -- the same
 estrogen a woman's ovaries produce before menopause -- directly through the
 skin and into the bloodstream for seven full days.  The estrogen in Climara is
 derived from natural plant sources (soy).
     Estrogens should not be used by patients with known or suspected
 pregnancy, breast cancer, estrogen-dependant neoplasia, undiagnosed abnormal
 genital bleeding, active thrombophlebitis, or thromboembolic disorders.
 Estrogens have been reported to increase the risk of endometrial carcinoma in
 women with a uterus.
     Committed to developing novel diagnostics and therapeutics that address
 unmet medical needs, Berlex Laboratories, Inc., the U.S. affiliate of Schering
 AG, Germany (NYSE:   SHR), researches, manufactures and markets ethical
 pharmaceuticals in five strategic areas: Diagnostic Imaging, Female
 Healthcare, Dermatology, Oncology and Therapeutics for life-threatening and
 disabling diseases.  Berlex has business operations located in Montville and
 Wayne, New Jersey, and in Richmond, California.  For more information on
 currently marketed products, please visit http://www.berlex.com.
     For further information about the Climara family of products, please visit
 http://www.climara-us.com or http://www.climararewards.com.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X29150011
 
 SOURCE  Berlex Laboratories, Inc.